Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (ACTRN12625001114437) titled 'Optimising Type 2 Diabetes Outcomes Utilising Continuous Glucose Monitoring and A Culturally Appropriate Primary Care Pharmacist Prescriber Model of Care' on Oct. 13.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Non-randomised trial
Masking: Open (masking not used)
Assignment: Single group
Type of endpoint: Safety/efficacy
Primary Sponsor: Health NZ
Condition:
Type 2 Diabetes
Type 2 Diabetes
Metabolic and Endocrine - Diabetes
Intervention:
This is a 13-week single arm study conducted in the Southern Region of New Zealand. All participants will be involved in the study for 15 w...